# Quotient Sciences

> Accelerating drug development process

Business model and tags: B2B, Has physical offices, Consulting, Manufacturing, Professional services, Sales-led purchase, Pharma & life sciences, Contract manufacturer, Sells to enterprises, Multi-site, International operations, Has production sites, Has in-house R&D, Handles regulated data

## About Quotient Sciences

A drug development and manufacturing accelerator offering integrated programs and tailored services to get drugs to patients faster and more efficiently

## Key facts

- **Industry**: Pharmaceutical Manufacturing
- **Company size**: 1,001–5,000 employees
- **Headquarters**: Nottingham, Nottinghamshire, United Kingdom
- **Revenue**: £73.3M – £579M (Tamtam estimate)
- **Website**: [quotientsciences.com](https://www.quotientsciences.com/?utm_source=LinkedIn&utm_medium=link&utm_content=LinkedIn+profile&utm_campaign=2023+Social+Media+Engagement)
- **LinkedIn**: [linkedin.com/company/quotient-sciences](https://www.linkedin.com/company/quotient-sciences)

## Jobs at Quotient Sciences

- [Senior Director, Business Development](https://www.linkedin.com/jobs/view/4487179683/) · San Diego, CA, United States · Nov 9, 2026
- [Senior Director Business Development](https://www.linkedin.com/jobs/view/4476279712/) · Chicago, IL, United States, Remote · Oct 9, 2026
- [Business Development Director, Early Phase Clinical Research (Biologics)](https://www.linkedin.com/jobs/view/4451204921/) · Philadelphia, PA, United States, Remote · Sep 25, 2026

[See all 4 openings](https://www.tamtam.ai/c/quotient-sciences/jobs)

## Quotient Sciences in the news

- [Quotient and Acesion partner on ai‑enhanced formulation](https://pharmatimes.com/news/quotient-and-acesion-partner-on-ai-enhanced-formulation/) · pharmatimes.com · Oct 6, 2026
  Quotient Sciences and Acesion Pharma are partnering to use AI-enhanced formulation development within Quotient's Translational Pharmaceutics platform to accelerate Acesion's early-stage drug pipeline for atrial fibrillation.
- [Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline](https://finance.yahoo.com/healthcare/articles/quotient-sciences-acesion-pharma-announce-094600604.html) · finance.yahoo.com · Oct 2, 2026
  Quotient Sciences and Acesion Pharma partnered to use AI-enhanced formulation development for atrial fibrillation treatments, aiming to speed up early clinical decisions.
- [Quotient Sciences, Acesion Pharma Partner on AI-Driven Drug Development](https://www.digitalhealthnews.com/quotient-sciences-acesion-pharma-partner-on-ai-driven-drug-development) · digitalhealthnews.com · Sep 30, 2026
  Quotient Sciences and Acesion Pharma are collaborating to integrate AI-enhanced formulation technology with Quotient Sciences' Translational Pharmaceutics platform to accelerate drug development for Acesion's atrial fibrillation pipeline.

[See all 20 articles](https://www.tamtam.ai/c/quotient-sciences/news)

## Quotient Sciences at a glance

Quotient Sciences is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Nottingham, Nottinghamshire, United Kingdom.

Quotient Sciences has 1,001–5,000 employees.

Quotient Sciences's revenue is £73.3M – £579M (Tamtam estimate).

Quotient Sciences is hiring: 4 recent open roles, including Senior Director, Business Development, Senior Director Business Development, Business Development Director, Early Phase Clinical Research (Biologics).

## Frequently asked questions about Quotient Sciences

### What is Quotient Sciences's revenue?

Tamtam estimates Quotient Sciences's annual revenue at £73.3M – £579M.

### How many employees does Quotient Sciences have?

Quotient Sciences has 1,001–5,000 employees.

### Where is Quotient Sciences headquartered?

Quotient Sciences is headquartered in Nottingham, Nottinghamshire, United Kingdom.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/quotient-sciences
